← All companies

ARDX

Ardelyx, Inc.

ARDX Nasdaq Pharmaceutical Preparations EDGAR ↗

$4.94

-0.07 -1.50%

Key statistics

from XBRL data in SEC filings

Market cap

$1.22B

Revenue (TTM)

$428M

Net income (TTM)

-$58.5M

EPS (TTM)

$-0.24

P/E ratio

—

Dividend yield

—

Free cash flow

-$44.0M

Cash

$31.2M

Total assets

$505M

Gross margin

1.1%

52-week range

$4.71 – $8.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Took on a direct financial obligation Jul 2, 2026 8-K Director or officer change; Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 19, 2026 8-K Results of operations (earnings release); Other events Jan 8, 2026 8-K Director or officer change; Other events Dec 17, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Director or officer change Oct 14, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release); Director or officer change; Amended charter or bylaws Aug 4, 2025 8-K Entered a material agreement Jul 3, 2025 8-K Director or officer change; Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 8-K Director or officer change Apr 29, 2025 10-K Fiscal year ended 2024-12-31 Feb 20, 2025 8-K Results of operations (earnings release) Feb 20, 2025 8-K Results of operations (earnings release); Other events Jan 13, 2025 8-K Director or officer change Nov 18, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 31, 2024 8-K Entered a material agreement Oct 9, 2024 8-K Entered a material agreement Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Other events Jul 2, 2024 8-K Director or officer change; Shareholder vote results Jun 17, 2024 8-K Other events May 23, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Took on a direct financial obligation Mar 5, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Results of operations (earnings release) Feb 22, 2024 8-K Results of operations (earnings release) Jan 8, 2024 8-K Director or officer change Nov 13, 2023 10-Q Quarter ended 2023-09-30 Oct 31, 2023 8-K Results of operations (earnings release) Oct 31, 2023